Lindenwold Advisors’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$2.44M Sell
18,196
-3,478
-16% -$368K 1.15% 23
2025
Q2
$2.11M Buy
21,674
+261
+1% +$20.7K 1.1% 28
2025
Q1
$1.56M Sell
21,413
-399
-2% -$31.4K 0.87% 37
2024
Q4
$1.58M Sell
21,812
-468
-2% -$35.5K 0.84% 39
2024
Q3
$1.82M Buy
22,280
+30
+0.1% +$2.61K 0.92% 36
2024
Q2
$2.37M Sell
22,250
-390
-2% -$37.4K 1.26% 24
2024
Q1
$2.2M Sell
22,640
-9,050
-29% -$796K 1.18% 31
2023
Q4
$2.48M Sell
31,690
-140
-0.4% -$9.54K 1.41% 18
2023
Q3
$2M Buy
31,830
+10
+0% +$657 1.24% 24
2023
Q2
$2.05M Sell
31,820
-6,130
-16% -$346K 1.25% 26
2023
Q1
$2.01M Buy
37,950
+600
+2% +$29.4K 1.25% 27
2022
Q4
$1.57M Buy
37,350
+100
+0.3% +$4.18K 1.05% 35
2022
Q3
$1.36M Buy
37,250
+430
+1% +$19.1K 1.01% 37
2022
Q2
$1.57M Buy
36,820
+710
+2% +$33.8K 1.12% 31
2022
Q1
$1.94M Buy
36,110
+480
+1% +$27.9K 1.19% 26
2021
Q4
$2.56M Buy
+35,630
New +$2.23M 1.5% 16

Other funds holding LRCX

Lindenwold Advisors's LRCX Position: Q3 2025 in Review

Lindenwold Advisors reduced its Lam Research (LRCX) stake by 16% in Q3 2025, selling an estimated $368K and leaving 18,196 shares worth $2.44M. The position accounts for 1.15% of the portfolio, ranked #23.

Lindenwold Advisors first reported a position in LRCX in Q4 2021 and has held it in 16 quarters since. The position peaked at $2.56M in Q4 2021. 2,108 funds tracked by Wall St. Rank hold LRCX as of Q3 2025.

  • Lindenwold Advisors held 18,196 shares of Lam Research worth $2.44M as of Q3 2025.
  • Lindenwold Advisors sold 3,478 Lam Research shares in Q3 2025, an estimated $368K.
  • Lam Research made up 1.15% of Lindenwold Advisors's portfolio in Q3 2025, its #23 holding.
  • Lindenwold Advisors first reported a position in Lam Research in Q4 2021 and has held it in 16 quarters since.
  • Lindenwold Advisors's Lam Research position peaked at $2.56M in Q4 2021.
  • 2,108 funds tracked by Wall St. Rank held Lam Research as of Q3 2025.

Based on Lindenwold Advisors's 13F filing for Q3 2025, filed 16 Dec 2025.